Thorell Marella — SEC Form 4 filings

SEC reporting owner CIK 1826323. 7 Form 4 filings on record with FilingPulse; latest filed 2026-07-10.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2024-03-27 to 2026-07-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Seres Therapeutics, Inc. (MCRB)See Remarks44
ESSA Pharma Inc. (EPIX)Director22
Carisma Therapeutics Inc. (CARM)Director11

Form 4 filings — Thorell Marella

FiledFormIssuerReported transactionsSource
2026-07-104Seres Therapeutics, Inc. (MCRB)Grant/award (A): 7,500 (derivative) @ $0EDGAR
2026-03-064Seres Therapeutics, Inc. (MCRB)Grant/award (A): 22,500 (derivative) @ $0EDGAR
2025-10-154ESSA Pharma Inc. (EPIX)Disposition to issuer (D): 2,881EDGAR
2025-02-114Seres Therapeutics, Inc. (MCRB)Grant/award (A): 650,000 (derivative) @ $0EDGAR
2024-07-014Carisma Therapeutics Inc. (CARM)Grant/award (A): 38,700 (derivative) @ $0EDGAR
2024-03-284ESSA Pharma Inc. (EPIX)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2024-03-274Seres Therapeutics, Inc. (MCRB)Grant/award (A): 700,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1826323 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →